- Home
- IKT vs SLND Comparison
IKT vs SLND Comparison
Compare IKT & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- SLND
- Stock Information
- Founded
- IKT 2008
- SLND 1900
- Country
- IKT United States
- SLND United States
- Employees
- IKT N/A
- SLND N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- IKT Health Care
- SLND Industrials
- Exchange
- IKT Nasdaq
- SLND Nasdaq
- Market Cap
- IKT 159.2M
- SLND 188.8M
- IPO Year
- IKT 2020
- SLND N/A
- Fundamental
- Price
- IKT $2.27
- SLND $3.02
- Analyst Decision
- IKT Strong Buy
- SLND Buy
- Analyst Count
- IKT 2
- SLND 2
- Target Price
- IKT $6.50
- SLND $5.50
- AVG Volume (30 Days)
- IKT 194.9K
- SLND 29.6K
- Earning Date
- IKT 03-26-2025
- SLND 03-03-2025
- Dividend Yield
- IKT N/A
- SLND N/A
- EPS Growth
- IKT N/A
- SLND N/A
- EPS
- IKT N/A
- SLND N/A
- Revenue
- IKT $1.00
- SLND $1,029,117,999.00
- Revenue This Year
- IKT N/A
- SLND N/A
- Revenue Next Year
- IKT N/A
- SLND $6.18
- P/E Ratio
- IKT N/A
- SLND N/A
- Revenue Growth
- IKT N/A
- SLND N/A
- 52 Week Low
- IKT $1.12
- SLND $1.85
- 52 Week High
- IKT $4.20
- SLND $6.16
- Technical
- Relative Strength Index (RSI)
- IKT 38.70
- SLND 35.69
- Support Level
- IKT $1.90
- SLND $3.00
- Resistance Level
- IKT $2.37
- SLND $3.59
- Average True Range (ATR)
- IKT 0.25
- SLND 0.16
- MACD
- IKT -0.07
- SLND -0.05
- Stochastic Oscillator
- IKT 34.91
- SLND 2.36
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.